Northwest Biotherapeutics | NWBO - Passività Correnti





Passività Correnti Cambiamento Data
Agenus USD 249.24M 74.25M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
Eisai JPY 340.25B 47.42B 2026-03
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Merck USD 26.94B 1.38B 2026-03
Northwest Biotherapeutics USD 87.9M 3.98M 2025-09
Pfizer USD 34.35B 2.64B 2026-03
Plus Therapeutics USD 7.96M 4.36M 2026-03
Roche Holding CHF 28B 421M 2025-12